Mark R. Litzow
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 465
- Acute Myeloid Leukemia Research 281
- Chronic Myeloid Leukemia Treatments 149
- Hematopoietic Stem Cell Transplantation 130
- Multiple Myeloma Research and Treatments 73
- Genetics 189
- Myeloproliferative Neoplasms: Diagnosis and Treatment 99
- Chronic Lymphocytic Leukemia Research 77
- Co-authors
- Martin S. TallmanAyalew TefferiHillard M. LazarusWilliam J. HoganJacob M. RoweSelina M. LugerElisabeth PaiettaMartha Q. Lacy
- Journals
- Blood (187 papers)Biology of Blood and Marrow Transplantation (43 papers)Journal of Clinical Oncology (34 papers)Bone Marrow Transplantation (29 papers)American Journal of Hematology (23 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Mark R. Litzow
569 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 11.9k
- Genetics 4.9k
- Oncology 4.8k
- Public Health, Environmental and Occupational Health 4.9k
- Immunology 2.3k
Countries citing papers authored by Mark R. Litzow
This map shows the geographic impact of Mark R. Litzow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Litzow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Litzow more than expected).
Fields of papers citing papers by Mark R. Litzow
This network shows the impact of papers produced by Mark R. Litzow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Litzow. The network helps show where Mark R. Litzow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Litzow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 9 | |
| 13 | 2018 | 52 | |
| 14 | 2018 | 4 | |
| 15 | 2017 | 31 | |
| 16 | 2016 | 38 | |
| 17 | 2010 | 182 | |
| 18 | In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) Hit paper breakdown → | 2007 | 537 |
| 19 | 2000 | 31 | |
| 20 | 2000 | 25 |
About Mark R. Litzow
Mark R. Litzow is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Transplantation and Oncology, having authored 597 papers that have together received 18.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (281 papers), Acute Lymphoblastic Leukemia research (173 papers), Chronic Myeloid Leukemia Treatments (149 papers), Hematopoietic Stem Cell Transplantation (130 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (99 papers), Chronic Lymphocytic Leukemia Research (77 papers), Multiple Myeloma Research and Treatments (73 papers) and Lymphoma Diagnosis and Treatment (35 papers). The work is most often cited by research in Hematology (11.9k citations), Genetics (4.9k citations), Oncology (4.8k citations), Public Health, Environmental and Occupational Health (4.9k citations) and Immunology (2.3k citations). Mark R. Litzow has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Martin S. Tallman, Ayalew Tefferi, Hillard M. Lazarus, William J. Hogan, Jacob M. Rowe, Selina M. Luger, Elisabeth Paietta, Martha Q. Lacy, Angela Dispenzieri and Morie A. Gertz. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.